Clinical Trials Browser

Phase 3 × Rectal Neoplasms × atezolizumab × Clear all

NCT05482516 2025-05-22

MRD-GI

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular, Rectal Neoplasms